These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19238933

  • 21. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA.
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [Abstract] [Full Text] [Related]

  • 22. Role of bronchodilators in chronic obstructive pulmonary disease.
    Weder MM, Donohue JF.
    Semin Respir Crit Care Med; 2005 Apr; 26(2):221-34. PubMed ID: 16088439
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment.
    Wood-Baker R, Cochrane B, Naughton MT.
    Intern Med J; 2010 Feb; 40(2):94-101. PubMed ID: 19849745
    [Abstract] [Full Text] [Related]

  • 25. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review.
    Restrepo RD.
    Respir Care; 2009 Aug; 54(8):1058-81. PubMed ID: 19650947
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Inhaled antimuscarinic drugs: cardiovascular toxicity.
    Prescrire Int; 2010 Jun; 19(107):122-3. PubMed ID: 20738041
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Current strategy of bronchodilator therapy for chronic obstructive pulmonary disease (COPD)].
    Teramoto S.
    Nihon Rinsho; 1999 Sep; 57(9):2051-5. PubMed ID: 10497405
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
    Osztovits J, Fehér J.
    Orv Hetil; 2010 May 02; 151(18):749-50. PubMed ID: 20410002
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of tiotropium on heart rate variability in stable chronic obstructive pulmonary disease patients.
    Wu YK, Huang CY, Yang MC, Huang GL, Chen SY, Lan CC.
    J Aerosol Med Pulm Drug Deliv; 2015 Apr 02; 28(2):100-5. PubMed ID: 24840562
    [Abstract] [Full Text] [Related]

  • 34. Safety, tolerability and risk benefit analysis of tiotropium in COPD.
    Oba Y, Zaza T, Thameem DM.
    Int J Chron Obstruct Pulmon Dis; 2008 Apr 02; 3(4):575-84. PubMed ID: 19281075
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Recent progress on the therapy for chronic obstructive pulmonary disease (COPD)--usefulness and practice of the step-by-step pharmacologic therapy].
    Ishii T, Matsuse T.
    Nihon Rinsho; 1999 Sep 02; 57(9):2035-40. PubMed ID: 10497402
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The first long-acting anticholinergic drug. COPD drug with 24-hour effect].
    MMW Fortschr Med; 2002 Jun 27; 144(26):52. PubMed ID: 12154479
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.